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The GM2 gangliosidosis are a group of metabolic dis-
orders in which deficiency of a lysosomal enzyme, hexo-
saminidase A (Hex A), leads to an abnormal intracellular 
accumulation of lipids in neurons and glia. Total deficiency 
is responsible for a fatal infantile disorder, Tay-Sachs dis-
ease, characterized by involution in motor abilities, hypo-
tonia, seizures and cortical blindness, with death around 5 
or 6 years-old. Partial deficiency of enzyme activity is as-
sociated with a variety of late-onset (teenagers and young 
adults) neurological phenotypes, characterized by upper 
and lower motor neuron signs, cerebellar disturbanc-
es, parkinsonism, and psychosis or dementia in different 
combinations1,2. Macular cherry red spots, which are typi-
cal for Tay-Sachs, are not apparent in these patients. All of 
the GM2 gangliosidosis subtypes are inherited in an auto-
somal recessive fashion and the differences in age at onset 
and disease course may be partly attributed to the under-
lying Hex A gene defect. Patients with infantile onset tend 
to be homozygous or compound heterozygote for severe, 
deleterious (“null”) alleles, whereas patients with late-on-
set disease have a combination of one severe and anoth-
er allele associated with residual Hex A activity3. Late on-
set GM2 gangliosidosis (LOGM2) is commonly included 
in the differential diagnosis of amyotrophic lateral scle-
rosis (ALS), due to the involvement of anterior horn cell, 
causing weakness, atrophy, cramps and fasciculations3,4. 
We report a patient with unusual clinical features of 
isolated upper motor neuron (UMN) involvement, resem-
bling primary lateral sclerosis (PLS).
CaSe
A 30-year-old Brazilian Caucasian man was referred to our 
department for neurological assessment due to an 8-year histo-
ry of progressive weakness involving the right side of his body. 
Insidiously, the symptoms progressed to his left leg and arm. He 
developed dysarthria and dysphagia. He also noted difficulty for 
recalling recent events. His past medical history was unremark-
able. Family history was negative for neurological disorders and 
his parents were not consanguineous. 
On neurological evaluation, his cognition was preserved. 
Neurological examination disclosed spastic tetraparesis (MRC 
4/5 in all limbs) with global hyperreflexia, including bilateral 
Babinski and Hoffman signs. There was bilateral VI nerve palsy, 
but examination with ophthalmoscope was normal. The patient 
did not present sphincterian damage.
Brain magnetic resonance imaging (MRI) showed a hyper-
intense signal along the pyramidal tract in FLAIR (Figure). Elec-
troneuromyography (ENMG) did not show signs of denervation 
Figure. MRI showing a hyperintense signal along the pyramidal tract in FLAIR (Black arrows).
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or reinervation, nerve conduction was normal, but there was an 
increased insertional activity on tested muscles. Although clin-
ical manifestations were similar to PLS, impairment of extraoc-
ular muscles and early onset impelled further investigation. The 
cerebrospinal fluid examination was normal, such as standard 
hematologic and biochemical tests: full blood count, erythro-
cyte sedimentation rate, glucose, urea and creatinine, electro-
lytes, liver function, thyroid function, B12 vitamin, ANA. Serol-
ogy for, HIV, HTLV-1, VDRL, hepatitis B and C were negative. The 
patient sera was also analyzed for hexosaminidase A by a flu-
orometric method: Hex A – 280 nmoles/h/mL (normal value: 
550–1.675) and 32% of total hexosaminidase (normal value: 45– 
70%). Due to these results, we concluded that patient`s signs 
and symptoms were due to partial Hex A deficiency.
Despite symptomatic treatment with baclofen the patient 
did not improve and is currently on follow-up. 
An informed consent was signed allowing data publication.
diSCuSSion
LOGM2 is rarely a potential cause for ALS-mimic syn-
dromes, and most commonly LMN symptoms are predom-
inant5. Early findings include decreased or absent triceps 
and patellar reflexes, an easy startle, primarily to light 
touch when unexpected, hand tremors, fasciculations, and 
a positive palmomentum reflex3. Our patient presented a 
progressive spastic tatra paresis, resembling PLS, which is 
uncommon for LOGM2. Moreover, brain MRI findings re-
vealed abnormal signal on corticospinal tract, as seen at 
typical ALS, and no other abnormalities6. This finding was 
uncommon, once brain imaging studies in patients with 
LOGM2 generally show severe cerebellar atrophy7.
 PLS is another rare disorder, characterized by a slowly 
progressive symmetrical pyramidal deficit occurring in the 
absence of muscle wasting and in which no other cause 
for the neurological dysfunction can be established8. The 
differential diagnosis for progressive corticospinal spas-
ticity is challenging. Many disorders, such as inherited 
illnesses or conditions with sensory symptoms or more 
generalized neurologic impairment, could be eliminated 
readily after a careful history and examination. Actually, 
if a patient presents with slowly progressive spinobulbar 
spasticity in the absence of other findings, the differen-
tial diagnosis is limited. The hereditary spastic paraplegias 
and familial ALS merit particular consideration4. If the pa-
tient is less than 40 years of age, Hex A levels could be of 
value to diagnose LOGM2, which may be quite difficult 
to distinguish from ALS on clinical examination. Although 
the motor manifestations of our patient were typical of 
a MND, some associated findings impelled us to find an 
alternative diagnosis: early manifestation, slow course and 
bilateral VI nerve palsy. The clinical features described in 
patients with Hex A deficiency and motor neuron symp-
toms include early onset, positive family history, and/or 
long disease duration1-3,5. 
Previous reports failed to reveal significant Hex A de-
ficiency among ALS patients. In one study, the frequency 
of mutations in the Hex A gene among Israeli ALS patients 
was not higher than in the healthy Israeli population5. In 
another one, Hex A activity determined in isolated pe-
ripheral blood leukocytes was screened in ALS patients, 
and was normal in all typical ALS patients9. In both studies 
there is no data regarding PLS.
This case report highlights that Hex A deficiency can 
mimic not only ALS, but also PLS. We believe that the 
screening for Hex A deficiency should always be consid-
ered in atypical cases of MND.
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